My NCBI | Sign In
Search: Patterson KC[au]
RSS Settings
  • Search: Patterson KC[au]

Display Settings:

Format

Send to:

Choose Destination

    Ann Intern Med. 2006 Jul 18;145(2):152-3.

    Imatinib mesylate in the treatment of refractory idiopathic pulmonary arterial hypertension.

    Patterson KC, Weissmann A, Ahmadi T, Farber HW.

    PMID: 16847299 [PubMed - indexed for MEDLINE]

    Publication Types, MeSH Terms, Substances

    Publication Types:

    MeSH Terms:

    Substances:

    LinkOut - more resources

    Full Text Sources:

    Medical:

    Molecular Biology Databases:

    Supplemental Content

    Click here to read

    Related articles

    Cited by 4 PubMed Central articles

    Patient drug information

    • Imatinib (Gleevec®)

      Imatinib is used to treat certain types of leukemia (cancer that begins in the white blood cells) and other cancers of the blood cells. Imatinib is also used to treat gastrointestinal stromal tumors (GIST; a type of tumo...

    • Source: AHFS Consumer Medication Information

    All links from this record

    • Related Articles

      Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.

    • Compound (MeSH Keyword)

      PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

    • Substance (MeSH Keyword)

      PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

    • Cited in PMC

      Full-text articles in the PubMed Central Database that cite the current articles.

    Search details

    » See more...

    Recent activity